These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 12387104)

  • 1. HIV medication adherence: from Haitian DOT to generics in Brazil.
    Jones SG
    Fla Nurse; 2002 Sep; 50(3):28. PubMed ID: 12387104
    [No Abstract]   [Full Text] [Related]  

  • 2. Working together to provide generics for health.
    Beck EJ; Reiss P
    Antivir Ther; 2014; 19 Suppl 3():1. PubMed ID: 25310234
    [No Abstract]   [Full Text] [Related]  

  • 3. Generic antiretrovirals for the treatment of HIV: a novel challenge for Western countries?
.
    Cattaneo D; Andreoni M; Carosi G; Cauda R; Lazzarin A; Rizzardini G
    Int J Clin Pharmacol Ther; 2017 May; 55(5):381-393. PubMed ID: 28211784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laboratory monitoring of HIV--after access to antiretroviral drugs, the next challenge for the developing world.
    Tucker T; Yeats J
    S Afr Med J; 2001 Aug; 91(8):615. PubMed ID: 11584766
    [No Abstract]   [Full Text] [Related]  

  • 5. Cheap HIV drugs for developing countries.
    Int J Epidemiol; 2001 Jun; 30(3):651-2. PubMed ID: 11460820
    [No Abstract]   [Full Text] [Related]  

  • 6. [HIV therapy: tenofir DF is available in 68 developing countries at production costs price].
    Med Klin (Munich); 2003 Jul; 98(7):XV-XVI. PubMed ID: 12945544
    [No Abstract]   [Full Text] [Related]  

  • 7. Antiretroviral therapy in resource-poor settings. Decreasing barriers to access and promoting adherence.
    Mukherjee JS; Ivers L; Leandre F; Farmer P; Behforouz H
    J Acquir Immune Defic Syndr; 2006 Dec; 43 Suppl 1():S123-6. PubMed ID: 17133195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV/AIDS: Latin America & Caribbean. Brazil: ten years after.
    Cohen J
    Science; 2006 Jul; 313(5786):484-7. PubMed ID: 16873654
    [No Abstract]   [Full Text] [Related]  

  • 9. HIV clinic improves medication adherence. DOT is latest experimental strategy.
    AIDS Alert; 2005 Mar; 20(3):28-9. PubMed ID: 15789471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generic drugs battle moves from South Africa to Kenya.
    Siringi S
    Lancet; 2001 May; 357(9268):1600. PubMed ID: 11377665
    [No Abstract]   [Full Text] [Related]  

  • 11. Affordable drug access for developing countries.
    Highleyman L
    BETA; 2001; 14(2):12-25. PubMed ID: 11785481
    [No Abstract]   [Full Text] [Related]  

  • 12. Affordable drug access for developing countries.
    Highleyman L
    BETA; 2001; 14(2):12-25. PubMed ID: 11702763
    [No Abstract]   [Full Text] [Related]  

  • 13. Dose reduction of antiretrovirals: a feasible and testable approach to expand HIV treatment in developing countries.
    Vento S; Lanzafame M; Lattuada E; Cainelli F; Restelli U; Foglia E
    Trop Med Int Health; 2013 Jan; 18(1):40-4. PubMed ID: 23094787
    [No Abstract]   [Full Text] [Related]  

  • 14. Affordable antiretroviral drugs for developing countries: dreams of the magic bullet.
    Razum O; Okoye S
    Trop Med Int Health; 2001 Jun; 6(6):421-2. PubMed ID: 11422954
    [No Abstract]   [Full Text] [Related]  

  • 15. AIDS treatment. Drugmakers test restrictions on generics in U.S. programs.
    Cohen J
    Science; 2004 Oct; 306(5694):213. PubMed ID: 15472049
    [No Abstract]   [Full Text] [Related]  

  • 16. Closing the affordability gap for drugs in low-income countries.
    Steinbrook R
    N Engl J Med; 2007 Nov; 357(20):1996-9. PubMed ID: 18003957
    [No Abstract]   [Full Text] [Related]  

  • 17. Highly active antiretroviral therapy (HAART)--plus: next steps to enhance HAART in resource-limited areas?
    Flanigan TP; Wools-Kaloustain K; Harwell J; Cu-Uvin S; Kimaiyo S; Carter EJ
    Clin Infect Dis; 2007 Dec; 45(11):1499-501. PubMed ID: 17990234
    [No Abstract]   [Full Text] [Related]  

  • 18. Adherence strategies. Inmates don't view DOT favorably. Privacy is biggest concern.
    AIDS Alert; 2006 Aug; 21(8):94-5. PubMed ID: 16913045
    [No Abstract]   [Full Text] [Related]  

  • 19. DAAT may work where DOT model fell short. Good results for drugs issued by methadone clinics.
    AIDS Alert; 2003 Jan; 18(1):8-9. PubMed ID: 12541996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simplifying HIV therapeutics, and the global treatment of AIDS.
    Laurence J
    AIDS Read; 2003 Jan; 13(1):5-6. PubMed ID: 12569889
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.